Novartis, the Basel, Switzerland-based maker of branded prescription medicines, had recently usurped Teva's place at the top of the generic heap with the acquisitions of Hexal and Eon.
Novartis (nyse: NVS - news - people ), the Basel, Switzerland-based maker of branded prescription medicines, had recently usurped Teva's place at the top of the generic heap with the acquisitions of Hexal and Eon.